Proposal for new calcineurin inhibitor listings on the Pharmaceutical Schedule

11 August 2020 - As part of PHARMAC’s Annual Tender process, PHARMAC is proposing to list two new medicines on ...

Read more →

Alkindi approved in Australia

10 August 2020 - Diurnal Group announces that Alkindi (hydrocortisone granules in capsules for opening) has been approved by the ...

Read more →

Can multi-criteria decision analysis be implemented into real world drug decision-making processes? A Canadian provincial experience

7 August 2020 - This paper describes the implementation of multi-criteria decision analysis into a Canadian public drug reimbursement decision-making process, ...

Read more →

SMC - August 2020 decisions

10 August 2020 - The Scottish Medicines Consortium has today published advice accepting neratinib (Nerlynx) for the treatment of breast ...

Read more →

Coronavirus: cancer patient's urgent plea for treatment in New Zealand

10 August 2020 - A Christchurch cancer patient is missing out on potentially life-saving treatment due to rising COVID-19 cases ...

Read more →

Gilead submits new drug application to U.S. Food and Drug Administration for Veklury (remdesivir) for the treatment of COVID-19

10 August 2020 - Veklury is currently available in the U.S. for the treatment of severe COVID-19 under an Emergency Use ...

Read more →

Coming of age: emerging health preference research based on established scientific standards

10 August 2020 - Value in Health themed section enhances the scientific respectability and relevance of health preference research. ...

Read more →

Return some excess drug revenues to employers, CLHIA says in submission to PMPRB

10 August 2020 - In its submission to the Patented Medicine Prices Review Board’s draft guidelines, the Canadian Life and ...

Read more →

Aquestive Therapeutics receives FDA fast track designation for AQST-108 (sublingual film formulation delivering systemic epinephrine) for treatment of allergic reactions including anaphylaxis

10 August 2020 - Finalising preparations for pharmacokinetic clinical trials of AQST-108. ...

Read more →

ICER to assess treatments for lupus nephritis

10 August 2020 - Report will be subject of New England CEPAC meeting in March 2021; Open Input now being accepted ...

Read more →

Communication@EMA

10 August 2020 - The European Medicines Agency has launched its third communication perception survey. ...

Read more →

Stephen Hahn MD, FDA chief, is caught between scientists and the President

10 August 2020 - Many medical experts - including members of his own staff - worry about whether Dr Hahn ...

Read more →

Ensuring access to emerging COVID-19 treatments through Medicare reimbursement policy

7 August 2020 - Effective pharmaceutical treatments for coronavirus disease 2019 (COVID-19) are urgently needed, and there has been an explosion ...

Read more →

'Tears of joy' as new drug ready for cystic fibrosis patient

8 August 2020 - A woman waiting for the approval of a delayed drug that could save her life says ...

Read more →

U.S. Food and Drug Administration approves Lampit (nifurtimox) for the treatment of Chagas disease in children

7 August 2020 - Only Chagas disease treatment approved in U.S. for use in children from birth to less than 18 ...

Read more →